Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
APLM similar filings
- 25 Apr 24 Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
- 28 Mar 24 Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
- 4 Mar 24 Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
- 19 Jan 24 Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- 8 Jan 24 Current report (foreign)
- 28 Sep 23 Index to Condensed Consolidated Interim Financial Statements
- 20 Jul 23 Current report (foreign)
Filing view
External links